What to Expect With RESTASIS®
How does RESTASIS® work?
RESTASIS® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.
How long does it take for RESTASIS® to work?
Chronic Dry Eye is a chronic condition, and you will need to maintain therapy on an ongoing basis. Within 1 month of therapy, your eyes may start producing more of their own tears, but it could take 3 to 6 months after beginning therapy to see an increase in tear production.
You may want to continue to use artificial tears, such as REFRESH® Brand or REFRESH® OPTIVE™ Lubricant Eye Drops, in conjunction with RESTASIS® Ophthalmic Emulsion. Your use of artificial tears may decrease as you begin to produce more of your own tears. Individual results may vary.
How should I use RESTASIS®?
Patients should use RESTASIS® Ophthalmic Emulsion twice a day, 12 hours apart, every day. One vial should be used every morning and another vial should be used every night. That’s why it is important that you get a full 30-day supply (2 trays—60 vials total) from your pharmacist.
RESTASIS® is packaged in convenient single-use droppers. A 30-day supply is 2 trays (60 vials total). Make sure your doctor and pharmacist provide this for you. One drop in each eye, twice a day, is the recommended dosage. Remember to throw away each vial after usage.
- To view how RESTASIS® Ophthalmic Emulsion works in action, see the TV commercial
- Get a $20 rebate toward your prescription!
Sign up now - See how staying on RESTASIS® therapy can help you save hundreds of dollars a year with the My Tears, My Rewards® Program.
Join now
Current members sign in here.
Two Trays For 30 Days
Need More Information?
Get a $20 rebate along with a FREE information kit.
Indication:
RESTASIS® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.
Important Safety Information:
RESTASIS® Ophthalmic Emulsion should not be used by patients with active eye infections and has not been studied in patients with a history of herpes viral infections of the eye. RESTASIS® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use.
The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.
Please see product information for RESTASIS® Ophthalmic Emulsion.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
© 2010 Allergan, Inc. All rights reserved | Privacy Statement | FAQs | Terms of Use | Site Map | Contact Us
This information is intended for residents of the United States. ® and ™ marks owned by Allergan, Inc.